Daily FNArena News - Australia

FNArena’s Reporting Season Monitor keeps track of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

Brokers appear confident CSL could beat guidance in FY18, thanks to a maiden profit from its flu vaccine, Seqirus. The core business is also expected to be strong.

FNArena’s Reporting Season Monitor keeps track of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

FNArena’s Reporting Season Monitor keeps track of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

JB Hi-Fi has stated intentions of chasing sales and market share at the expense of gross margins. Brokers diverge on the degree of success anticipated over the next several years.

FNArena’s Reporting Season Monitor keeps track of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

FNArena’s Reporting Season Monitor keeps track of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

A more modest growth story is likely from REA Group in the second half yet brokers expect the company to maintain its dominance and still produce strong listings volumes.

Are banks in Australia (finally) a good buy? An update on the pros and cons that lay ahead for the sector in the coming months.

FNArena’s Reporting Season Monitor keeps track of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.